What is My Size's earnings per share (EPS)?

My Size (MYSZ) reported diluted earnings per share of $-1.87 for fiscal year 2025. This represents a 57.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

My Size Financials

MYSZ

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows My Size (MYSZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MYSZ FY2025 2026-05-14

Sales growth has not yet translated into self-funding because My Size’s model still converts added revenue into cash burn.

FY2024 looked like a turn toward operating leverage, but FY2025 reversed it as revenue reached $9.4M while gross margin slipped to 32.0%. With free cash flow burn widening to -$5.2M from -$3.1M, the extra sales were carrying weaker economics rather than improving the company’s ability to fund itself.

Because free cash flow was almost identical to operating cash flow in FY2025 (-$5.2M versus -$5.1M), the cash drain came from day-to-day operations rather than heavy reinvestment. That makes this a business-model burn issue, not a capital-intensity issue; capex was too small to explain the shortfall.

The balance sheet is still not debt-driven, with balance-sheet leverage remaining modest and short-term coverage above 1x. But cash fell to $2.3M while financing supplied $3.0M in FY2025, so liquidity was being maintained by fresh capital rather than by the business generating its own cash.

Financial Health Signals

Financial Profile 49/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of My Size's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

My Size has an operating margin of -61.3%, meaning the company retains $-61 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -47.8% the prior year.

Growth

My Size's revenue grew 13.4% year-over-year to $9.4M, a solid pace of expansion. This earns a growth score of 59/100.

Leverage

My Size carries a low D/E ratio of 0.16, meaning only $0.16 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

My Size's current ratio of 1.87 indicates adequate short-term liquidity, earning a score of 33/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While My Size generated -$5.1M in operating cash flow, capex of $16K consumed most of it, leaving -$5.2M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

100

My Size earns a strong 113.5% return on equity (ROE), meaning it generates $113 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100. This is up from 57.8% the prior year.

Piotroski F-Score Weak

3/9

My Size passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

-0.88x

For every $1 of reported earnings, My Size generates $-0.88 in operating cash flow (-$5.1M OCF vs $5.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$9.4M

YoY+13.4%

5Y CAGR+131.1%

My Size generated $9.4M in revenue in fiscal year 2025. This represents an increase of 13.4% from the prior year.

EBITDA

-$5.4M

YoY-48.7%

My Size's EBITDA was -$5.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 48.7% from the prior year.

Net Income

$5.9M

YoY+46.5%

My Size reported $5.9M in net income in fiscal year 2025. This represents an increase of 46.5% from the prior year.

EPS (Diluted)

$-1.87

YoY+57.4%

My Size earned $-1.87 per diluted share (EPS) in fiscal year 2025. This represents an increase of 57.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$5.2M

YoY-66.4%

My Size generated -$5.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 66.4% from the prior year.

Cash & Debt

$2.3M

YoY-52.8%

5Y CAGR+6.4%

10Y CAGR+9.6%

My Size held $2.3M in cash against $831K in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+127.4%

My Size had 5M shares outstanding in fiscal year 2025. This represents an increase of 127.4% from the prior year.

Margins & Returns

Gross Margin

32.0%

YoY-8.2pp

5Y CAGR-66.5pp

My Size's gross margin was 32.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 8.2 percentage points from the prior year.

Operating Margin

-61.3%

YoY-13.5pp

5Y CAGR+4266.9pp

My Size's operating margin was -61.3% in fiscal year 2025, reflecting core business profitability. This is down 13.5 percentage points from the prior year.

Net Margin

62.5%

YoY+14.1pp

5Y CAGR+4398.4pp

My Size's net profit margin was 62.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 14.1 percentage points from the prior year.

Return on Equity

113.5%

YoY+55.7pp

5Y CAGR+410.1pp

My Size's ROE was 113.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 55.7 percentage points from the prior year.

Capital Allocation

R&D Spending

$597K

YoY+39.2%

5Y CAGR-17.1%

10Y CAGR+7.1%

My Size invested $597K in research and development in fiscal year 2025. This represents an increase of 39.2% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$16K

YoY+128.6%

5Y CAGR+0.0%

10Y CAGR-10.2%

My Size invested $16K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 128.6% from the prior year.

MYSZ Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$9.4M+13.4%	$8.3M+18.0%	$7.0M+56.9%	$4.5M+3303.8%	$131K-7.7%	$142K
Cost of Revenue	$6.4M+28.9%	$4.9M+15.7%	$4.3M+11.5%	$3.8M	N/A	$2K
Gross Profit	$3.0M-9.7%	$3.3M+21.7%	$2.7M+330.8%	$634K+384.0%	$131K-6.4%	$140K
R&D Expenses	$597K+39.2%	$429K-56.0%	$974K-42.7%	$1.7M-60.0%	$4.2M+178.9%	$1.5M
SG&A Expenses	$4.8M+42.1%	$3.4M-15.2%	$4.0M+1.8%	$3.9M-5.4%	$4.1M+60.7%	$2.6M
Operating Income	-$5.7M-45.5%	-$3.9M+41.5%	-$6.7M+16.9%	-$8.1M+23.3%	-$10.6M-72.1%	-$6.1M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	-$333K-825.0%	-$36K	N/A	N/A
Net Income	$5.9M+46.5%	$4.0M+162.6%	-$6.4M+23.2%	-$8.3M+21.0%	-$10.5M-70.9%	-$6.2M
EPS (Diluted)	$-1.87+57.4%	$-4.39	$-20.40	$-7.47	N/A	$-1.11

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$2.4M+3527.3%	$66K-97.4%	$2.6M+28.2%	$2.0M+35.6%	$1.5M+1.6%	$1.5M-20.9%	$1.8M-7.1%	$2.0M
Cost of Revenue	$1.5M	N/A	$1.6M+77.2%	$882K-16.7%	$1.1M-4.0%	$1.1M+5.2%	$1.0M+5.3%	$995K
Gross Profit	$940K	N/A	$1.0M-10.2%	$1.1M+167.6%	$420K+19.3%	$352K-55.5%	$791K-19.6%	$984K
R&D Expenses	$239K	N/A	$131K-7.7%	$142K+73.2%	$82K+6.5%	$77K-13.5%	$89K-32.1%	$131K
SG&A Expenses	$1.2M	N/A	$1.0M+10.6%	$904K+8.8%	$831K+4.4%	$796K+24.4%	$640K-28.8%	$899K
Operating Income	-$1.4M	N/A	-$1.4M-131.4%	-$586K+44.7%	-$1.1M-53.6%	-$690K+47.2%	-$1.3M-48.9%	-$877K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$1.5M	N/A	-$1.3M-196.7%	-$450K+57.5%	-$1.1M-114.6%	$7.3M+659.6%	-$1.3M-34.9%	-$964K
EPS (Diluted)	$-0.31	N/A	$-0.40-166.7%	$-0.15+70.6%	$-0.51	N/A	$-1.25+2.3%	$-1.28

MYSZ Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$10.2M+1.4%	$10.1M+11.9%	$9.0M-7.6%	$9.7M-22.5%	$12.6M+252.2%	$3.6M
Current Assets	$7.7M-14.7%	$9.1M+36.9%	$6.6M+9.4%	$6.1M-47.6%	$11.6M+368.5%	$2.5M
Cash & Equivalents	$2.3M-52.8%	$4.9M+123.1%	$2.2M+4.1%	$2.1M-80.3%	$10.7M+531.7%	$1.7M
Inventory	$3.0M+8.5%	$2.8M-2.9%	$2.9M+188.8%	$997K	N/A	N/A
Accounts Receivable	$1.2M+336.7%	$278K-54.8%	$615K-68.3%	$1.9M+4750.0%	$40K+42.9%	$28K
Goodwill	$640K+381.2%	$133K-82.5%	$758K-45.7%	$1.4M	N/A	N/A
Total Liabilities	$5.0M+60.2%	$3.1M-26.0%	$4.3M-18.0%	$5.2M+205.2%	$1.7M+14.2%	$1.5M
Current Liabilities	$4.1M+37.9%	$3.0M-22.7%	$3.9M-7.2%	$4.2M+240.3%	$1.2M+34.8%	$911K
Long-Term Debt	$831K+469.2%	$146K-41.4%	$249K-33.8%	$376K	N/A	N/A
Total Equity	$5.2M-25.4%	$6.9M+45.9%	$4.7M+4.4%	$4.5M-58.2%	$10.9M+423.0%	$2.1M
Retained Earnings	-$69.7M-9.2%	-$63.9M-6.7%	-$59.9M-11.9%	-$53.5M-18.4%	-$45.2M-30.3%	-$34.7M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$8.5M-16.8%	$10.2M-12.4%	$11.7M+18.2%	$9.9M+12.7%	$8.8M-13.0%	$10.1M+43.0%	$7.0M-12.2%	$8.0M
Current Assets	$6.2M-20.0%	$7.7M-14.8%	$9.1M+8.0%	$8.4M+7.8%	$7.8M-14.0%	$9.1M+52.5%	$5.9M-4.1%	$6.2M
Cash & Equivalents	$654K-71.6%	$2.3M-48.7%	$4.5M+4.9%	$4.3M+15.9%	$3.7M-24.3%	$4.9M+105.8%	$2.4M-25.9%	$3.2M
Inventory	$3.4M+12.4%	$3.0M-9.3%	$3.3M+15.3%	$2.9M+15.9%	$2.5M-10.4%	$2.8M+24.9%	$2.2M+24.8%	$1.8M
Accounts Receivable	$890K-26.7%	$1.2M+139.9%	$506K+27.1%	$398K-25.5%	$534K+92.1%	$278K-15.0%	$327K-0.6%	$329K
Goodwill	$634K-0.9%	$640K-6.7%	$686K+383.1%	$142K+6.8%	$133K0.0%	$133K+1.5%	$131K-1.5%	$133K
Total Liabilities	$4.5M-10.2%	$5.0M+15.8%	$4.4M+78.0%	$2.4M-10.1%	$2.7M-13.6%	$3.1M+22.4%	$2.6M+11.1%	$2.3M
Current Liabilities	$3.7M-11.3%	$4.1M+23.9%	$3.3M+54.2%	$2.2M-16.5%	$2.6M-13.7%	$3.0M+25.6%	$2.4M+13.1%	$2.1M
Long-Term Debt	$788K-5.2%	$831K-0.1%	$832K+804.3%	$92K-30.8%	$133K-8.9%	$146K-17.5%	$177K-8.3%	$193K
Total Equity	$4.0M-23.3%	$5.2M-29.3%	$7.3M-1.6%	$7.4M+23.0%	$6.0M-12.7%	$6.9M+55.0%	$4.5M-21.7%	$5.7M
Retained Earnings	-$71.2M-2.1%	-$69.7M-4.5%	-$66.7M-2.0%	-$65.4M-0.7%	-$64.9M-1.7%	-$63.9M-1.1%	-$63.2M-2.1%	-$61.9M

MYSZ Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$5.1M-66.3%	-$3.1M+49.4%	-$6.1M+16.2%	-$7.3M+0.1%	-$7.3M-28.5%	-$5.7M
Capital Expenditures	$16K+128.6%	$7K0.0%	$7K-74.1%	$27K+17.4%	$23K+43.8%	$16K
Free Cash Flow	-$5.2M-66.4%	-$3.1M+49.3%	-$6.1M+16.5%	-$7.3M0.0%	-$7.3M-28.5%	-$5.7M
Investing Cash Flow	-$196K-469.8%	$53K+857.1%	-$7K+99.3%	-$993K-716.8%	$161K+176.3%	-$211K
Financing Cash Flow	$3.0M-46.5%	$5.6M-8.8%	$6.1M+9255.2%	-$67K-100.4%	$16.3M+167.3%	$6.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$2.1M+11.4%	-$2.3M-367.2%	-$500K+51.8%	-$1.0M+18.1%	-$1.3M-122.8%	-$569K-27.3%	-$447K+32.2%	-$659K
Capital Expenditures	$46K	$0	$0	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	-$2.1M+9.5%	-$2.3M-367.2%	-$500K	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$46K	$0+100.0%	-$142K	N/A	N/A	-$7K	$0	$0
Financing Cash Flow	$453K+58.9%	$285K-65.2%	$820K-54.3%	$1.8M+1789.5%	$95K-96.8%	$3.0M+986.0%	-$335K-113.1%	$2.6M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MYSZ Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	32.0%-8.2pp	40.2%+1.2pp	39.0%+24.8pp	14.2%-85.8pp	100.0%+1.4pp	98.6%
Operating Margin	-61.3%-13.5pp	-47.8%+48.6pp	-96.4%+85.5pp	-181.9%+7892.2pp	-8074.0%-3745.9pp	-4328.2%
Net Margin	62.5%+14.1pp	48.4%+139.6pp	-91.2%+95.2pp	-186.4%+7844.2pp	-8030.5%-3694.6pp	-4335.9%
Return on Equity	113.5%+55.7pp	57.8%+192.6pp	-134.7%+48.5pp	-183.2%-86.3pp	-96.9%+199.7pp	-296.6%
Return on Assets	57.4%+17.6pp	39.7%+110.7pp	-71.0%+14.5pp	-85.4%-1.7pp	-83.8%+88.9pp	-172.7%
Current Ratio	1.87-1.2	3.03+1.3	1.71+0.3	1.45-8.0	9.42+6.7	2.71
Debt-to-Equity	0.16+0.1	0.02-0.0	0.05-0.0	0.08-0.1	0.16-0.6	0.72
FCF Margin	-55.1%-17.6pp	-37.5%+49.9pp	-87.4%+76.7pp	-164.1%+5423.7pp	-5587.8%-1577.2pp	-4010.6%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	39.3%	N/A	39.2%-16.8pp	56.0%+27.6pp	28.4%+4.2pp	24.2%-18.8pp	43.0%-6.7pp	49.7%
Operating Margin	-58.7%	N/A	-52.7%-23.5pp	-29.2%+42.5pp	-71.7%-24.3pp	-47.4%+23.6pp	-71.0%-26.7pp	-44.3%
Net Margin	-61.7%	N/A	-51.9%-29.5pp	-22.4%+49.2pp	-71.7%-571.7pp	500.0%+570.7pp	-70.7%-22.0pp	-48.7%
Return on Equity	-37.3%	N/A	-18.3%-12.2pp	-6.1%+11.5pp	-17.6%-122.9pp	105.3%+134.5pp	-29.2%-12.2pp	-16.9%
Return on Assets	-17.4%	N/A	-11.5%-6.9pp	-4.6%+7.5pp	-12.1%-84.4pp	72.3%+90.8pp	-18.5%-6.5pp	-12.0%
Current Ratio	1.69-0.2	1.87-0.9	2.73-1.2	3.89+0.9	3.02-0.0	3.03+0.5	2.49-0.4	2.94
Debt-to-Equity	0.20+0.0	0.16+0.0	0.11+0.1	0.010.0	0.020.0	0.02-0.0	0.040.0	0.03
FCF Margin	-88.3%+3451.0pp	-3539.4%-3519.9pp	-19.4%	N/A	N/A	N/A	N/A	N/A

Similar Companies

Freight Tech FRGT

$2.3M

Auddia Inc AUUD

$8.0M

Treasure Global Inc. TGL

$6.5M

Urgent.ly ULY

$11.8M

Youxin Technology Ltd YAAS

$18.7M

Frequently Asked Questions

What is My Size's annual revenue?

My Size (MYSZ) reported $9.4M in total revenue for fiscal year 2025. This represents a 13.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is My Size's revenue growing?

My Size (MYSZ) revenue grew by 13.4% year-over-year, from $8.3M to $9.4M in fiscal year 2025.

Is My Size profitable?

Yes, My Size (MYSZ) reported a net income of $5.9M in fiscal year 2025, with a net profit margin of 62.5%.

What is My Size's EBITDA?

My Size (MYSZ) had EBITDA of -$5.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does My Size have?

As of fiscal year 2025, My Size (MYSZ) had $2.3M in cash and equivalents against $831K in long-term debt.

What is My Size's gross margin?

My Size (MYSZ) had a gross margin of 32.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is My Size's operating margin?

My Size (MYSZ) had an operating margin of -61.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is My Size's net profit margin?

My Size (MYSZ) had a net profit margin of 62.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is My Size's return on equity (ROE)?

My Size (MYSZ) has a return on equity of 113.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is My Size's free cash flow?

My Size (MYSZ) generated -$5.2M in free cash flow during fiscal year 2025. This represents a -66.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is My Size's operating cash flow?

My Size (MYSZ) generated -$5.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are My Size's total assets?

My Size (MYSZ) had $10.2M in total assets as of fiscal year 2025, including both current and long-term assets.

What are My Size's capital expenditures?

My Size (MYSZ) invested $16K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does My Size spend on research and development?

My Size (MYSZ) invested $597K in research and development during fiscal year 2025.

How many shares does My Size have outstanding?

My Size (MYSZ) had 5M shares outstanding as of fiscal year 2025.

What is My Size's current ratio?

My Size (MYSZ) had a current ratio of 1.87 as of fiscal year 2025, which is generally considered healthy.

What is My Size's debt-to-equity ratio?

My Size (MYSZ) had a debt-to-equity ratio of 0.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is My Size's return on assets (ROA)?

My Size (MYSZ) had a return on assets of 57.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is My Size's cash runway?

Based on fiscal year 2025 data, My Size (MYSZ) had $2.3M in cash against an annual operating cash burn of $5.1M. This gives an estimated cash runway of approximately 5 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is My Size's Piotroski F-Score?

My Size (MYSZ) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are My Size's earnings high quality?

My Size (MYSZ) has an earnings quality ratio of -0.88x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is My Size?

My Size (MYSZ) scores 49 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.